Monitoring percent free PSA in serial specimens: Improvement of test specificity, early detection, and identification of occult tumors

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 1, 1998, Pages 26-31

  Wu, James T ^a   Liu, Grace H ^b   Zhang, Ping ^b   Stephenson, Robert A ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

Benign prostate hyperplasia; BPH; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ARTICLE; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT CANCER; PATIENT MONITORING; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATITIS;

HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0031890328     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:1<26::AID-JCLA5>3.0.CO;2-H     Document Type: Article

References (19)

1. Wu JT: Assay for prostate specific antigen (PSA): Current problems and possible solutions. J Clin Lab Anal 8:51-62, 1994.
2. Wu JT Serum prostate specific antigen assay - An update. Western J Med (Epitomes-Pathology) 162:447-448, 1995.
3. Oesterling JE: Prostate specific antigen: a critical assessment of the most useful rumor marker for adenocarcinoma of the prostate. J Urol 145:907-923, 1991.
4. Lilja H, Cockett ATK, Abrahamsson P-A: Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Cancer Supplement 70:230-234, 1992.
5. Wu JT, Zhang P, Wang T, et al.: Evaluation of free PSA isoforms, PSA complex formation and specificity of anti-PS A antibodies by HPLC and PAGE-immunoblotting techniques. J Clin Lab Anal 9:1-14, 1995.
6. Wu JT, Wilson L, Zhang P, Meikle WA, Stephenson RA: Correlation of serum concentrations of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer. J Clin Lab Anal 9:15-20, 1995.
7. Catalona W, Smith D, Ratliff T, et al.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156-1161, 1991.
8. Catalona WJ, Smith DS, Wolfert RL, et al.: Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 274:1214-1220, 1995.
9. Vashi AR, Oesterling JE: Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer. Mayo Clin Proc 72:337-334, 1997.
10. Hudson MA, Bahnson RR, Catalona WJ: Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142:1011-1017, 1989.
11. Catalona WJ, Colberg JW, Smith DS, et al.: Measurement of percent-free PSA improves specificity for lower PSA cutoffs in prostate cancer screening. J Urol 155:422A, 1996.
12. Wu JT, Stephenson RA: Microplate assays for free PSA, PSA-ACT and total PSA: Assay characteristics, selection of calibrators and in vitro stability studies. Proceeding of the 1st International Consultation on Prostate Cancer, 1997, p 159-168.
13. Chan DW, Bruzek DJ, Oesterling JE, et al.: Prostate-specific antigen as a marker for prostate cancer: A monoclonal and a polyclonal immunoassay compared. Clin Chem 3:1916-1920, 1987.
14. van Duijnhoven HLP, Pequeriaux NCV, van Zon John PHM, Blankenstein MA: Large discrepancy between prostate-specific antigen results from different assays during longitudinal follow-up of a prostate cancer patient. Clin Chem 42:637-641, 1996.
15. Oesterling JE, Jacobsen SJ, Chute CG, et al.: Serum prostate-specific antigen m a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 270:860-864, 1993.
16. Oesterling JE, Jacobsen SJ, Cooner WH. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older. J Urol 153:1160-1163, 1995.
17. Babaian RJ, Camps JL, Frangos DN, et al.: Monoclonal prostate-specific antigen in untreated prostate cancer: Relationship to clinical stage and grade. Cancer 67:2200-2206, 1991.
18. Kojima M, Babaian RJ: Algorithms for early detection of prostate cancer: Current state of the "art". Cancer 75:1860-1868, 1995.
19. Murphy GP, Barren RJ, Erickson SJ, et al.: Evaluation and comparison of two new prostate carcinoma markers: Free-prostate specific antigen and prostate specific membrane antigen. Cancer 78:809-818, 1996.